Latest News and Press Releases
Want to stay updated on the latest news?
-
LAS VEGAS, Feb. 22, 2011 (GLOBE NEWSWIRE) -- Skinvisible, Inc. (OTCQB:SKVI) announced that the Canadian Patent Office has issued a Notice of Allowance for the comprehensive technology patent for...
-
LAS VEGAS, Feb. 1, 2011 (GLOBE NEWSWIRE) -- Skinvisible Pharmaceuticals, Inc. (OTCBB:SKVI) and (OTCQB:SKVI) has entered into a feasibility agreement with Novartis Pharma AG. Under the agreement...
-
LAS VEGAS, Dec. 14, 2010 (GLOBE NEWSWIRE) -- Further to its press release of April 13, 2010, Skinvisible, Inc. (OTCBB:SKVI) is pleased to announce it has entered into an exclusive licensing...
-
LAS VEGAS, Oct. 14, 2010 (GLOBE NEWSWIRE) -- Skinvisible, Inc. (OTCBB:SKVI) (OTCQB:SKVI) is pleased to announce that RHEI Pharmaceuticals HK Ltd. (RHEI), a subsidiary of the Luxembourg-based...
-
LAS VEGAS, July 27, 2010 (GLOBE NEWSWIRE) -- Skinvisible, Inc. (OTCBB:SKVI) announced today the Hong Kong Patent Office has issued the Company a patent (No. HK1066971) covering its unique polymer...
-
LAS VEGAS, July 20, 2010 (GLOBE NEWSWIRE) -- Skinvisible, Inc. (OTCBB:SKVI), the developers of Invisicare, and RHEI Pharmaceuticals HK Ltd. , a Hong Kong-based pharmaceutical company and a subsidiary...
-
LAS VEGAS, July 13, 2010 (GLOBE NEWSWIRE) -- Skinvisible, Inc. (OTCBB:SKVI) and RHEI Pharmaceuticals, a Hong Kong-based pharmaceutical company and a subsidiary of the Luxembourg-based Leeward Ventures...
-
LAS VEGAS, April 13, 2010 (GLOBE NEWSWIRE) -- Skinvisible, Inc. (OTCBB:SKVI) is pleased to announce it has entered into a research and development agreement with Women's Choice Pharmaceuticals...
-
LAS VEGAS, March 23, 2010 (GLOBE NEWSWIRE) -- Skinvisible, Inc. (OTCBB:SKVI) announced today that the South Korean patent office has granted a patent for Invisicare®, the company's polymer...
-
LAS VEGAS, Jan. 28, 2010 (GLOBE NEWSWIRE) -- Skinvisible, Inc.’s (OTCBB:SKVI) licensee, JD Nelson and Associates LLC, announced today that reorders have been received as a result of the...